Abnormal Conduction Zone Detected by Isochronal Late Activation Mapping Accurately Identifies the Potential Atrial Substrate and Predicts the Atrial Fibrillation Ablation Outcome After Pulmonary Vein Isolation

Background: The presence of abnormal substrate of left atrium is a predictor of atrial fibrillation (AF) recurrence after pulmonary vein isolation. We aimed to investigate the isochronal late activation mapping to access the abnormal conduction velocity for predicting AF ablation outcome. Methods: Forty-five paroxysmal AF patients (30 males, 57.8±8.7 years old) who underwent pulmonary vein isolation were enrolled. Isochronal late activation mapping was retrospectively constructed with 2 different windows of interest: from onset of P wave to onset of QRS wave on surface electrocardiography (W1) and 74 ms tracking back from the end of P wave (W2). Deceleration zone was defined as regions with 3 isochrones (DZa) or ≥4 isochrones (DZb) within a 1 cm radius on the isochronal late activation mapping, and the estimated conduction velocity (ECV) are 0.27 m/s and <0.20 m/s for DZa and DZb, respectively in W2. The distribution of deceleration zone was compared with the location of low-voltage zone (bipolar voltage ≤0.5 mV). Any recurrence of atrial arrhythmias was defined as the primary end point during follow ups after a 3-month blanking period. Results: Pulmonary vein isolation was performed in all patients, and there were 2 patients (4.4%) received additional extrapulmonary vein ablation. After a mean follow-up of 12.7±4.5 months, recurrence of AF occurred in 14 patients (31.1%). Patients with the presence of DZb in W2 had higher AF recurrence (Kaplan-Meier event rate estimates: HR, 9.41 [95% CI, 2.61–33.90]; log-rank P<0.0001). There were 52.6% of the DZb locations in W2 comparable to the distributions of low-voltage zone and 47.4% DZb were distributed in the area without low-voltage zone. Conclusions: Deceleration zone detected by isochronal late activation mapping represents a critical AF substrate, it accurately predicts the AF recurrence following ablation in patients with paroxysmal AF.

[1]  T. Chao,et al.  Low voltage zones detected by omnipolar Vmax map accurately identifies the potential atrial substrate and predicts the AF ablation outcome after PV isolation , 2021, International Journal of Cardiology.

[2]  M. Ishihara,et al.  Is the abnormal conduction zone of the left atrium a precursor to a low voltage area in patients with atrial fibrillation? , 2020, Journal of cardiovascular electrophysiology.

[3]  M. Asai,et al.  Slow whole left atrial conduction velocity after pulmonary vein isolation predicts atrial fibrillation recurrence , 2020, Journal of cardiovascular electrophysiology.

[4]  Andrew D. Beaser,et al.  Targeted Ablation of Ventricular Tachycardia Guided by Wavefront Discontinuities During Sinus Rhythm: A New Functional Substrate Mapping Strategy. , 2019, Circulation.

[5]  P. Sanders,et al.  Dynamic Atrial Substrate During High-Density Mapping of Paroxysmal and Persistent AF: Implications for Substrate Ablation. , 2019, JACC. Clinical electrophysiology.

[6]  Jun Pu,et al.  Low voltage areas in paroxysmal atrial fibrillation: The prevalence, risk factors and impact on the effectiveness of catheter ablation. , 2018, International journal of cardiology.

[7]  M. Masuda,et al.  Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. , 2018, International journal of cardiology.

[8]  F. Neumann,et al.  The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome After Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation. , 2018, JACC. Clinical electrophysiology.

[9]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  Rajiv Mahajan,et al.  Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis. , 2017, Heart, lung & circulation.

[11]  M. Uematsu,et al.  Influence of underlying substrate on atrial tachyarrhythmias after pulmonary vein isolation. , 2016, Heart rhythm.

[12]  K. Cao,et al.  Catheter Ablation of Nonparoxysmal Atrial Fibrillation Using Electrophysiologically Guided Substrate Modification During Sinus Rhythm After Pulmonary Vein Isolation , 2016, Circulation. Arrhythmia and electrophysiology.

[13]  Kawal S. Rhode,et al.  Repeat Left Atrial Catheter Ablation: Cardiac Magnetic Resonance Prediction of Endocardial Voltage and Gaps in Ablation Lesion Sets , 2015, Circulation. Arrhythmia and electrophysiology.

[14]  Marmar Vaseghi,et al.  Relationship Between Sinus Rhythm Late Activation Zones and Critical Sites for Scar-Related Ventricular Tachycardia: Systematic Analysis of Isochronal Late Activation Mapping , 2015, Circulation. Arrhythmia and electrophysiology.

[15]  Christopher Piorkowski,et al.  Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation , 2014, Circulation. Arrhythmia and electrophysiology.

[16]  H. Kottkamp.  Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. , 2013, European heart journal.

[17]  Gernot Plank,et al.  Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation. , 2013, Biophysical journal.

[18]  Haran Burri,et al.  Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  H. Kottkamp.  Fibrotic Atrial Cardiomyopathy: A Specific Disease/Syndrome Supplying Substrates for Atrial Fibrillation, Atrial Tachycardia, Sinus Node Disease, AV Node Disease, and Thromboembolic Complications , 2012, Journal of cardiovascular electrophysiology.

[20]  H. Kottkamp.  Atrial fibrillation substrate: the "unknown species"-- from lone atrial fibrillation to fibrotic atrial cardiomyopathy. , 2012, Heart rhythm.

[21]  Atul Verma,et al.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial† , 2010, European heart journal.

[22]  Takeshi Tsuchiya,et al.  Bipolar electrogram amplitudes in the left atrium are related to local conduction velocity in patients with atrial fibrillation. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  A. Garfinkel,et al.  Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: A computational study. , 2009, Heart rhythm.

[24]  Yu-Feng Hu,et al.  Efficacy of Additional Ablation of Complex Fractionated Atrial Electrograms for Catheter Ablation of Nonparoxysmal Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[25]  S. Rohr.  Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? , 2009, Heart rhythm.

[26]  L. Lo,et al.  The Efficacy of Inducibility and Circumferential Ablation with Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[27]  P. Filzmoser,et al.  Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor? , 2006, European heart journal.

[28]  S. Ernst,et al.  Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique , 2005, Circulation.

[29]  Mandeep Bhargava,et al.  Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. , 2005, Journal of the American College of Cardiology.

[30]  A. Oto,et al.  Maximum P-Wave Duration and P-Wave Dispersion Predict Recurrence of Paroxysmal Atrial Fibrillation in Patients with Wolff-Parkinson-White Syndrome after Successful Radiofrequency Catheter Ablation , 2004, Journal of Interventional Cardiac Electrophysiology.

[31]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[32]  F. Esmailian,et al.  Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation , 2004, Circulation.

[33]  Wei-Shiang Lin,et al.  Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy , 2003, Circulation.

[34]  Zoltan Szalay,et al.  Structural correlate of atrial fibrillation in human patients. , 2002, Cardiovascular research.

[35]  W. Stevenson,et al.  Catheter Ablation in Patients With Multiple and Unstable Ventricular Tachycardias After Myocardial Infarction: Short Ablation Lines Guided by Reentry Circuit Isthmuses and Sinus Rhythm Mapping , 2001, Circulation.

[36]  F. Marchlinski,et al.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. , 2000, Circulation.

[37]  C. Tai,et al.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.

[38]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.